The Regulatory Environment in Australia and New Zealand

The Regulatory Environment in Australia and New Zealand
Get an overview on the regulatory framework for medicines and processes in Australia and New Zealand, including expedited pathways.

 This is a recording of a webinar which took place in June 2020



Webinars photoThis webinar will outline the regulatory environment for medicine and the basic processes for registration in Australia and New Zealand. It will also present the available expedited pathways and will also compare and contrast the two countries.



Learning objectives

After attending this webinar participants will:

  • Have an overview on the regulatory environment in Australia and New Zealand
  • Understand the basic process for registration in Australia and New Zealand
  • Understand the differences in regulatory processes 
  • Learn about expedited pathways in the two regions

Target Audience

Regulatory affairs professionals with 2-5 years' experience who are interested in the current processes and updates for Australia and New Zealand.  Professional who want to build on their general regulatory knowledge of major submissions and strategies for expedited pathways.


Jennifer Svec

Regulatory Consultant 

After completing a PhD in Pharmacology at the University of Melbourne, Jennifer started working in the pharmaceutical industry in regulatory affairs in 1987.  This gives her more than 33 years in regulatory affairs, and the industry, including work in big pharma (until 2004) and as a freelance consultant now for more than 15 years. most of her work has focused on prescription medicines (with a short period in generics) and mainly in submissions and strategies supporting clinical-based regulatory submissions (from CTN and CTX applications, NCE/NBE submissions, clinical variations - extensions of indications, orphan drug designations and literature based submissions).  In addition to developing and delivering in-house training for clients, Jennifer has also acted as global regulatory lead for several early development products.  As a result of working in the industry for over 30 years Jennifer has established professional relationships with staff at both TGA and Medsafe and maintains a wide network within the Australian industry, collaborating closely with other freelance consultants in areas including clinical research, toxicology evaluation and pharmacoeconomics, as well as regulatory affairs.  

Jennifer is part of the Working team for the TOPRA CRED Orphan drugs Program.


This course offers 1 CPD hours for successful completion. To learn why CPD is important visit our Lifelong Learning page.

How do I register?

Simply log in or create an account and register below. 


Type Member  Non-member 
Standard    £70 + VAT £95 + VAT 

Discounted Places

A limited number of discounted places are available at the rates below for those:

Please email for a discount code before making your booking.

Type Member  Non-member 
Discount  £35 + VAT*  £47.50 + VAT* 

* VAT, if applicable, is charged at a rate of 20%.

Terms and conditions

By purchasing this webinar, you are agreeing to the terms and conditions.

Asia Pacific ONLINE
Your company name
Your VAT country
Your VAT number
Important instructions before booking - If your company name or VAT number does not appear here or you would like to be invoiced using a different VAT number, please email

Register now